mycoepoxydiene

structure in first source

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 06/01/2015 - "Here, we identified nicotinic-mycoepoxydiene (NMD), a structurally novel compound as Hsp90 inhibitor to perform the anti-tumor activity. " 06/01/2011 - "Culture media and fermentation conditions for cultivation of an endophytic fungus Phomopsis sp. Hant25 were investigated in order to improve the yield of mycoepoxydiene, a novel fungal metabolite having potent cytotoxic activity against many cancer cell lines. " 01/01/2015 - "Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth."
2.	Atherosclerosis 01/01/2015 - "Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice."
3.	Cholangiocarcinoma 06/01/2014 - "Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway."
4.	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/01/2015 - "Mycoepoxydiene (MED) can inhibit Hsp90 function and induce apoptosis in cervical cancer cells. " 01/01/2015 - "Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth."
5.	Anaphylaxis (Anaphylactic Shock) 10/01/2013 - "Mycoepoxydiene inhibits antigen-stimulated activation of mast cells and suppresses IgE-mediated anaphylaxis in mice."

1.	Phosphotransferases (Kinase)
2.	Immunoglobulin E (IgE)
3.	Heat-Shock Proteins (Heat-Shock Protein)
4.	Culture Media
5.	Apolipoproteins E (ApoE)
6.	Antigens